Filing Details
- Accession Number:
- 0001455244-10-000101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-26 13:00:00
- Reporting Period:
- 2010-04-26
- Filing Date:
- 2010-04-26
- Accepted Time:
- 2010-04-26 17:24:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
919722 | Supergen Inc | SUPG | Pharmaceutical Preparations (2834) | 911841574 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1360509 | Florian Schonharting | Oestergade 5, 3Rd Floor Dk-1100 Copenhagen K G7 | No | No | Yes | No | |
1360573 | Christian Hansen | Oestergade 5, 3Rd Floor Dk-1100 Copenhagen K G7 | No | No | Yes | No | |
1451330 | K/S Equity Public Nb | Oestergade 5, 3Rd Floor Dk-1100 Copenhagen K G7 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 21,965 | $3.08 | 6,114,052 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 45,300 | $3.09 | 6,068,752 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 300 | $3.10 | 6,068,452 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 14,035 | $3.10 | 6,054,417 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 10,224 | $3.11 | 6,044,193 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 3,161 | $3.12 | 6,041,032 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 2,772 | $3.13 | 6,038,260 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 863 | $3.16 | 6,037,397 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 7,087 | $3.17 | 6,030,310 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 2,193 | $3.18 | 6,028,117 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 4,900 | $3.19 | 6,023,217 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 1,200 | $3.20 | 6,022,017 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-04-26 | 1,000 | $3.20 | 6,021,017 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owners.
- Christian Hansen and Florian Sch?nharting are direct investors in a limited partner in the Fund and directors of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Each of Messrs. Hansen and Sch?nharting disclaim beneficial ownership in the securities, except to the extent of their pecuniary interest therein.